Romeo Okwara

4-3 Defensive End

  • 2019 Salary Cap Charge: $1,788,853
  • % of 2019 Team Cap: 0.92%
  • 2019 Cash Payout: $3,600,000
  • % of 2019 Team Cash Spending: 1.86%
  • 2019 Cash to Cap Ratio: 2.01
  • Total Contract Value: $6,800,000
  • Annual Contract Value: $3,400,000
  • Position Ranking: 30/131 at 43DE
  • Fully Guaranteed Money: $3,425,000
  • Age: 24
  • Height: 6' 5"
  • Weight: 265
  • College: Notre Dame
  • Accrued Seasons: 4
  • Entry: 2016 Undrafted Free Agent (Giants)
  • Year Signed: 2019 (RFA)
  • Free Agency: 2021 (UFA)
  • 2019 OTC Valuation: $3,664,000

Contract Notes

Romeo Okwara signed a 3 year extension with the Detroit Lions on March 5, 2019.  The contract includes a $2.705 million signing bonus and $720,000 guaranteed salary in 2019.  The contract automatically voids 5 days after the 2021 super bowl.

Current Contract

(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
201924$720,000$901,666$0$125,000$50,000$720,000$1,788,8531.0%
2020 📝
March 20: $150,000 roster bonus due
25$2,750,000$901,666$150,000$250,000$50,000$0$4,101,6662.1%
2021 📝
February 15: Last year (2021) of contract auto voids 5 days after Super Bowl
26$0$901,668$0$0$0$0$901,668--
Total$3,470,000$2,705,000$150,000$375,000$100,000$720,000$6,792,187
Embed This Contract
<iframe src="https://overthecap.com/contract-embed/5296/" width="600" height="275" frameborder="0" scrolling="no"></iframe>
Career Earnings: $5,141,295
Career APY: $1,285,324
Potential Earnings: $8,341,295
Total Guarantees: $3,480,000
Largest Cash Payment: $3,600,000 (2019)
Largest Cap Hit: $4,101,666 (2020)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
GiantsUDFATerminated20163$1,635,000$545,000$27,500$911,29555.7%$455,648
LionsUDFAExpired20163$1,635,000$545,000$27,500$630,00038.5%$630,000
LionsRFAActive20192$6,800,000$3,400,000$3,425,000$3,600,00052.9%$3,600,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Giants2$911,295$455,648$906,2950.0%$5,0000.0%
Lions2$4,230,000$2,115,000$2,418,8530.0%$00.0%

Salary Cap History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2016Giants$450,000$5,000$0$0$0$12,500$455,0000.3%$465,000
2017Giants$540,000$5,000$0$0$0$0$451,2950.3%$446,295
2018Lions$630,000$0$0$0$0$0$630,0000.4%$630,000
2019Lions$720,000$901,666$0$125,000$50,000$720,000$1,788,8531.0%$3,600,000
2020Lions$2,750,000$901,666$150,000$250,000$50,000$0$4,101,6662.1%$3,200,000
2021Lions$0$901,668$0$0$0$0$901,668--$0
Total$5,090,000$2,715,000$150,000$375,000$100,000$732,500$8,328,482$8,341,295
Dead Money History
TeamYearCap ChargeCash Paid
Giants2018$5,000$5,000
Total$5,000$5,000

Statistics

YearGames PlayedGames MissedSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2016160033.2%40.1%111115242000000
20176917.4%5.8%1200010000000
2018150172.4%9.0%28117.5388141001000
2019142052.8%17.8%14141.581100001000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$3,193,000$3,400,000
Injury Adjusted$3,816,813$2,975,000
test
OTC Valuation $3.5M $7.1M $10.6M $14.1M $17.6M APY $3.9M $7.8M $11.8M $15.7M $19.6M $7,830,000 $7,500,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.